Latest News

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other...

Key Insights The considerable ownership by retail investors in Shakti Pumps (India) indicates that they collectively...

With a price-to-earnings (or "P/E") ratio of 43.5x CRISIL Limited ( NSE:CRISIL ) may be sending very bearish signals at...

Key Insights Significantly high institutional ownership implies Tata Consultancy Services' stock price is sensitive to...

Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. Active...

Vascon Engineers Limited ( NSE:VASCONEQ ) shares have had a horrible month, losing 30% after a relatively good period...

Waterdrop (NYSE:WDH) has followed up its latest quarter with solid headline numbers, as Q2 2025 revenue came in at about CNY 838 million and basic EPS landed at roughly CNY 0.39, which sets the stage for another year of profitability momentum. The company has seen revenue move from roughly CNY 676 million in Q2 2024 to about CNY 838 million in Q2 2025, while basic EPS has climbed from around CNY 0.24 to CNY 0.39 over the same period. This gives investors a cleaner, more scalable earnings...

Okta (OKTA) has just posted Q3 2026 numbers with revenue of $742 million and basic EPS of $0.24, while on a trailing twelve month basis revenue sits at about $2.8 billion with EPS of $1.12 as the business continues to consolidate its move into sustained profitability. Looking back over recent quarters, revenue has stepped up from $682 million in Q4 2025 and $665 million in Q3 2025, alongside basic EPS rising from $0.13 and $0.09 in those periods. This sets the stage for investors to focus on...

CrowdStrike Holdings (CRWD) just posted Q3 2026 results with revenue of about $1.2 billion and a basic EPS loss of $0.14, keeping the focus firmly on scaling the top line while chipping away at losses. The company has seen quarterly revenue move from roughly $964 million in Q2 2025 to $1.23 billion in Q3 2026. Basic EPS has shifted from a $0.19 profit in Q2 2025 to a $0.44 loss in Q1 2026 and then narrowed to a $0.14 loss this quarter. This progression positions investors to pay close...

Investors may wish to note that the Executive Director of Prime Financial Group Limited , Matthew Murphy, recently...

Azrieli Group (TASE:AZRG) just posted another quarter of growth, with third quarter and nine month sales and profits climbing versus last year. Investors now need to judge how durable this trend looks. See our latest analysis for Azrieli Group. Even with those stronger earnings, the recent 30 day share price return of minus 7.29 percent and softer 7 day move suggest momentum has cooled a bit, though the 5 year total shareholder return of 77.77 percent still points to a rewarding long term...

Marvell Technology (MRVL) has turned in a punchy Q3 2026 print, with revenue of about $2.1 billion and basic EPS of $2.22, while net income (excluding extra items) came in at $1.9 billion as the latest marker of its profitability turnaround. The company has seen revenue move from $1.52 billion in Q3 2025 to $2.07 billion in Q3 2026 alongside a swing in net income from a loss of $676.3 million to a $1.9 billion profit, setting up a quarter where margins look materially healthier and far more...

Janux Therapeutics recently reported positive updated interim Phase 1 data for its PSMA-directed TRACTr candidate JANX007 in metastatic castration-resistant prostate cancer, based on 109 treated patients as of the October 15, 2025 cutoff, and held a virtual event on December 1 to discuss the results. The update highlights not only progress for JANX007 but also reinforces Janux’s broader TRACTr and ARM platforms, which span multiple solid tumors and an emerging CD19 program in autoimmune...

Asana (ASAN) just posted its Q3 2026 numbers, with revenue at about $201 million and basic EPS at roughly -$0.29. This keeps the focus firmly on how quickly the business can convert top line scale into a path toward profitability. The company has seen revenue move from around $179 million in Q2 2025 to roughly $201 million in Q3 2026, while basic EPS over that span has hovered between about -$0.31 and -$0.17. That sets up this quarter as another check in on whether margins are starting to...

The recent earnings posted by Lagenda Properties Berhad ( KLSE:LAGENDA ) were solid, but the stock didn't move as much...

Provaris Energy Ltd ( ASX:PV1 ) is possibly approaching a major achievement in its business, so we would like to shine...

China Motor Bus Company, Limited ( HKG:26 ) has announced that it will pay a dividend of HK$1.80 per share on the 6th...

Last week, Rapid Critical Metals Limited ( ASX:RCM ) insiders, who had purchased shares in the previous 12 months were...

Shandong Boan Biotechnology (HKG:6955) has had a rough three months with its share price down 27%. However, stock...

Ideally, your overall portfolio should beat the market average. But the main game is to find enough winners to more...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Insiders who bought Atomo Diagnostics Limited ( ASX:AT1 ) stock in the last 12 months were richly rewarded last week...